| Literature DB >> 30519184 |
Ruth A Cromarty1, Julia Schumacher1, Sara Graziadio2, Peter Gallagher3, Alison Killen1, Michael J Firbank1, Andrew Blamire4, Marcus Kaiser1,5, Alan J Thomas1, John T O'Brien6, Luis R Peraza1,5, John-Paul Taylor1.
Abstract
Lewy body dementia (LBD) and Alzheimer's disease (AD) are common forms of dementia that have different clinical profiles but are both commonly associated with attentional deficits. The aim of this study was to investigate efficiency of different attentional systems in LBD and AD and its association with brain structural abnormalities. We studied reaction time (RT) data from 45 LBD, 31 AD patients and 22 healthy controls (HCs) using the Attention Network Test (ANT) to assess the efficiency of three different attentional systems: alerting, orienting and executive conflict. Voxel-based morphometry (VBM) was used to investigate relations between different attention components and cortical volume. Both dementia groups showed slower overall RTs than controls, with additional slowing in LBD relative to AD. There was a significant alerting effect in controls which was absent in the dementia groups, the executive conflict effect was greater in both dementia groups compared to controls, but the orienting effect did not differ between groups. Mean RT in AD was negatively correlated with occipital gray matter (GM) volume and in LBD orienting efficiency was negatively related to occipital white matter (WM) volume. Given that previous studies in less impaired patients suggest a maintenance of the alerting effect, the absent alerting effect in our study suggests a loss of alerting efficiency with dementia progression. While orienting was largely preserved, it might be related to occipital structural abnormalities in LBD. Executive function was markedly impaired in both dementia groups, however, the absence of relations to brain volume suggests that it might be more related to functional rather than macrostructural pathophysiological changes.Entities:
Keywords: Parkinson’s disease dementia; alerting; attention network test; dementia with Lewy bodies; executive conflict; orienting; reaction times; voxel-based morphometry
Year: 2018 PMID: 30519184 PMCID: PMC6251343 DOI: 10.3389/fnagi.2018.00347
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Figure 1Depiction of a single trials of the modified Attention Network Test (ANT).
Demographics and clinical information; mean (standard deviation).
| HC ( | AD ( | LBD ( | Between-group differences | |
|---|---|---|---|---|
| Male: female | 15:7 | 24:7 | 38:7 | |
| Age | 75.9 (5.4) | 77.1 (7.9) | 74.5 (6.3) | |
| AChEI | na | 28 | 39 | |
| Dopaminergic medication | na | 0 | 33 | |
| Duration | na | 3.9 (2.1) | 3.1 (2.1) | |
| MMSE | 29.2 (0.9) | 21.1 (3.7) | 23.3 (3.8) | |
| CAMCOG | 96.7 (3.7) | 68.8 (13.3) | 75.9 (12.6) | |
| UPDRS | 1.1 (1.4) | 2.4 (2.2) | 20.5 (9.3) | |
| CAF total | na | 0.8 (1.7)f | 5.1 (4.5)g | |
| Mayo total | na | 9.1 (4.1)f | 13.5 (5.8)g | |
| Mayo cogn | na | 1.8 (1.8)f | 2.8 (1.9)g | |
| NPI total | na | 6.9 (6.2)f | 13.4 (9.7) | |
| NPI hall | na | 0.03 (0.2)f | 1.8 (2.0) |
AChEI, number of patients taking acetylcholinesterase inhibitors; AD, Alzheimer’s disease; CAF total, Clinical Assessment of Fluctuations total score; CAMCOG, Cambridge Cognitive Examination; Duration, duration of cognitive symptoms in years; HC, healthy controls; LBD, Lewy body dementia; Mayo Fluctuations, Mayo Fluctuations cognitive subscale; MMSE, Mini Mental State Examination; na, not applicable; Dopaminergic medication, number of patients taking dopaminergic medication; UPDRS, Unified Parkinson’s Disease Rating Scale III; NPI, Neuropsychiatric Inventory; NPI hall, NPI hallucination subscore. .
Mean reaction time (RT) from correct trials (ms) for each task condition (cue × target), for the controls, AD and LBD patients.
| HC ( | AD ( | LBD ( | ||
|---|---|---|---|---|
| All trials | 964.6 (147.5) | 1319.8 (322.6) | 1558.3 (391.0) | |
| No Cue | Overall | 1025.1 (162.6) | 1363.2 (325.3) | 1587.0 (377.4) |
| Congruent | 806.7 (110.2) | 1059.8 (270.2) | 1280.4 (288.4) | |
| Incongruent | 1243.4 (241.4) | 1666.6 (402.4) | 1893.6 (491.9) | |
| Neutral | Overall | 978.9 (147.3) | 1334.1 (309.5) | 1585.9 (413.0) |
| Congruent | 795.7 (98.8) | 1072.0 (267.7) | 1293.7 (302.6) | |
| Incongruent | 1162.0 (222.4) | 1596.1 (383.6) | 1878.2 (553.6) | |
| Spatial | Overall | 900.00 (136.4) | 1262.0 (342.9) | 1502.0 (395.8) |
| Congruent | 710.5 (89.5) | 989.1 (314.1) | 1245.7 (355.7) | |
| Incongruent | 1069.5 (203.5) | 1534.9 (411.0) | 1758.4 (478.9) | |
| Congruent | Overall | 771.0 (97.6) | 1040.3 (278.0) | 1273.3 (302.8) |
| Incongruent | Overall | 1158.3 (220.8) | 1599.2 (393.0) | 1843.4 (496.4) |
| Alerting | 46.2 (37.0)* | 29.14 (80.84) | 1.1 (93.7) | |
| Orienting | 88.9 (35.0)* | 72.07 (74.62)* | 83.9 (112.9)* | |
| Executive conflict | 387.4 (171.9)* | 558.88 (217.13)* | 570.1 (254.2)* |
Standard deviations are presented in brackets. AD, Alzheimer’s disease; HC, healthy controls; LBD, Lewy body dementia; *Significant attention network test (ANT) effect, .
Results from statistical tests for raw and normalized RTs.
| Effect significance, raw RT | Effect significance, normalized RT | ||
|---|---|---|---|
| HC-AD | (−578.9, −131.4), | ||
| HC-LBD | (−802.5, −384.9), | ||
| AD-LBD | (−425.9, −51.2), | ||
| Alerting | (4.9, 46.1), | (0.011, 0.038), | |
| Orienting | (58.7, 104.5), | (0.055, 0.085), | |
| HC Cue | |||
| Alerting | (0.026, 0.068), | ||
| Orienting | (0.073, 0.111), | ||
| AD Cue | |||
| Alerting | (−0.003, 0.047), | ||
| Orienting | (0.037, 0.089), | ||
| LBD Cue | |||
| Alerting | (−0.015, 0.026), | ||
| Orienting | (0.03, 0.080), | ||
| HC | Executive | ||
| AD | Executive | ||
| LBD | Executive | ||
| ANOVA | |||
| HC-AD | (−0.010, 0.060), | ||
| HC-LBD | (0.009, 0.074), | ||
| AD-LBD | (−0.013, 0.046), | ||
| ANOVA | |||
| ANOVA | |||
| HC-AD | (−325.5, −17.55), | (−0.111, 0.049), | |
| HC-LBD | (−326.4, −39.1), | (−0.039, 0.111), | |
| AD-LBD | (−140.2, 117.7), | (−0.0001, 0.134), |
Repeated measures (cue × target) ANOVA effects with group (HC, AD, LBD) as between-subject factor (.
Figure 2(A) Mean reaction times (RTs) overall and for the different cue and target conditions of the ANT within each group. (B) ANT effects from raw RTs. (C) ANT effects from normalized RTs. In each boxplot the central line corresponds to the sample median, the upper and lower border of the box represent the 25th and 75th percentile, respectively, and the length of the whiskers is 1.5 times the interquartile range. Corresponding results from statistical comparisons between the three groups are presented in Table 3. AD, Alzheimer’s disease; HCs, healthy controls; LBD, Lewy body dementia.
Figure 3Correlations between global cognition and mean RT with FDR-corrected p-values < 0.05 in the AD group. MMSE, Mini Mental State Examination; CAMCOG, Cambridge Cognitive Examination.
Figure 4Significant clusters from voxel-based morphometry (VBM) analysis. (A) Negative correlation between mean RT and gray matter (GM) volume at left lingual gyrus in the AD group. (B) Negative correlation between the size of the orienting effect and white matter (WM) volume at right lateral occipital cortex in the LBD group. Information on all uncorrected results can be found in Supplementary Tables S7–S10.